Publications by authors named "Julie E Dierksheide"

Abdominal vascular trauma, primarily due to penetrating mechanisms, is uncommon. However, when it does occur, it can be quite lethal, with mortality ranging from 20% to 60%. Increased early mortality has been associated with shock, acidosis, hypothermia, coagulopathy, free intraperitoneal bleeding and advanced American Association for the Surgery of Trauma Organ Injury Scale grade.

View Article and Find Full Text PDF

Posttransplantation lymphoproliferative disorder (PTLD) is a devastating post-transplantation complication often associated with Epstein-Barr virus (EBV). Although the type and length of immunosuppression are risk factors, a patient's inherent immune capacity also likely contributes to this disorder. This report uses severe-combined immunodeficient mice given injections of human peripheral blood leukocytes (hu PBL-SCID [Severe Combined Immunodeficient] mice) to test the hypothesis that cytokine genotype associates with the development of EBV-associated lymphoproliferative disease (LPD).

View Article and Find Full Text PDF

Purpose: On the basis of preclinical studies, we hypothesized that interleukin (IL)12 would potentiate the antitumor actions of an antihuman epidermal growth factor receptor-2 (HER2) monoclonal antibody (trastuzumab). We conducted a Phase I trial to determine the safety and optimal biological dose of IL-12 when given in combination with trastuzumab.

Patients And Methods: Patients with metastatic HER2-positive malignancies received trastuzumab on day 1 of each weekly cycle.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Julie E Dierksheide"

  • Julie E Dierksheide's research primarily focuses on trauma surgery, immunology, and the treatment of malignancies, with significant attention given to the mechanisms and consequences of abdominal vascular trauma and its associated mortality risks.
  • Her article on abdominal vascular trauma highlights the critical association between patient conditions such as shock and coagulopathy and the high mortality rates encountered in such cases, emphasizing the need for prompt medical intervention.
  • Additionally, her work in immunology has explored the relationships between genetic factors and the risk of Epstein-Barr virus-related lymphoproliferative disorders in immunocompromised hosts, as well as the potential of interleukin 12 to enhance the efficacy of treatments for HER2-overexpressing cancers.